Prazosin (Minipress) and Ketamine Therapy | Tovani Health
Minipress (Prazosin) — Alpha-1 adrenergic blocker (PTSD nightmares, hypertension, BPH)
Verdict at Tovani Health
Compatible and commonly co-prescribed for PTSD; we monitor BP.
Prazosin and ketamine are compatible. Many of our PTSD patients are already on prazosin for trauma-related nightmares. The interaction we plan around is BP: prazosin lowers it, ketamine raises it transiently, and the orthostatic recovery period after a session can be more pronounced.
If you take Minipress regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Minipress interacts with ketamine
Prazosin selectively blocks alpha-1 adrenergic receptors. It is the only medication with consistent evidence for PTSD nightmares. Orthostatic hypotension is the dominant side effect, especially with the first dose.
What we do at intake
Disclose dose and how long you have been on it. Take at bedtime as typically prescribed. Stand up slowly after sessions, especially in the early weeks of therapy.
Bottom line
Prazosin and ketamine are compatible. Many of our PTSD patients are already on prazosin for trauma-related nightmares. The interaction we plan around is BP: prazosin lowers it, ketamine raises it transiently, and the orthostatic recovery period after a session can be more pronounced.
Frequently Asked Questions
I take prazosin for PTSD nightmares. Will KAP make my nightmares worse or better?
Most PTSD patients see improvement in nightmares with KAP. We typically keep prazosin on board through the early course and reassess.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Minipress (Prazosin) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535
Comprehensive clinical pharmacokinetics/pharmacodynamics review of ketamine including CYP-mediated drug interactions (CYP3A4, CYP2B6).
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.